TT
Turn Therapeutics Inc.
TTRX · NASDAQ
$14.94 +8.26% (+$1.14)
1M +57.93%
Market Cap $411.7M
P/E Ratio -
Div. Yield -
ROE 280.41%
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 599.33x
PEG N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 49.80%
ROIC 84.66%
Asset turnover 0.00x
Debt
11 /100
High Int. coverage -17.50x
Debt/Equity 8.91x
Current ratio 1.19x
Stability
0 /100
Unstable Beta 2.05x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TTRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Bradley E. Burnam
Employees
2
Headquarters
Westlake Village
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report